TIANSHAN BIO(300313)
Search documents
天山生物(300313) - 2018 Q2 - 季度财报
2018-08-24 16:00
Financial Performance - Total revenue for the reporting period reached ¥207,982,884.10, an increase of 160.93% compared to ¥79,709,203.56 in the same period last year[18]. - Net profit attributable to shareholders was ¥13,630,970.92, representing a significant increase of 711.53% from ¥1,679,663.25 year-on-year[18]. - The net profit after deducting non-recurring gains and losses was ¥11,451,288.64, a turnaround from a loss of ¥2,771,971.55 in the previous year, marking a 513.11% increase[18]. - Basic earnings per share rose to ¥0.0578, up 580.00% from ¥0.0085 in the same period last year[18]. - Total assets at the end of the reporting period were ¥3,539,331,942.54, a 412.24% increase from ¥690,949,583.86 at the end of the previous year[18]. - Net assets attributable to shareholders increased to ¥2,169,808,216.95, up 496.82% from ¥363,562,015.92 at the end of the previous year[18]. - Operating profit reached CNY 22.48 million, up 957.48% compared to the previous year[68]. - Total profit amounted to CNY 22.63 million, reflecting a year-on-year increase of 794.17%[68]. - The company reported a cumulative net profit estimate of CNY 5,810,000 for the year, representing a significant increase of 2706.36% compared to the previous year[113]. - The basic earnings per share are projected to rise to CNY 0.2221, reflecting a growth of 2015.24% year-on-year[113]. Business Operations - The company has a focus on expanding its market presence and enhancing its product offerings in the livestock sector[11]. - The company expanded its business model by acquiring Elephant Advertising, establishing a dual business structure of livestock and outdoor advertising media operations[25]. - The company plans to diversify its resource acquisition methods, including self-development, bidding, and mergers and acquisitions, to support business growth[28]. - The company has adapted its business model to include overseas pasture management services, catering to international clients[37]. - The company is actively involved in the production of various meat products, including sausages and canned meats, with trademarks registered for these items[56]. - The company is focused on mitigating exchange rate risks associated with fluctuations in the AUD/CNY exchange rate, enhancing its foreign exchange talent and strategies[124]. Market and Industry Trends - The advertising industry is closely tied to macroeconomic fluctuations, with potential risks to Elephant Advertising's performance during economic downturns as companies may reduce their brand communication budgets[117]. - The advertising industry in China is experiencing rapid growth, with an annual growth rate exceeding GDP growth, and the company plans to expand media resource coverage and enhance operational control to mitigate performance risks[118]. - The company anticipates sustained demand for high-end purebred beef cattle in China due to domestic shortages and supportive government policies[123]. Compliance and Governance - The board of directors and management have confirmed the accuracy and completeness of the financial report, assuming legal responsibility for any misstatements[3]. - The company is committed to maintaining transparency and accountability in its financial disclosures and operations[3]. - The company has committed to ensuring the accuracy and completeness of information provided during the asset restructuring process, with ongoing compliance with legal obligations[130]. - The company has pledged to uphold the independence of its board and management personnel, ensuring no cross-employment with other controlled entities[142]. Risks and Challenges - The company has faced various risks, which are detailed in the report, along with corresponding mitigation strategies[4]. - The livestock industry faces significant risks from animal diseases, which can severely impact production and profitability, but the company has implemented preventive measures and maintains a high level of animal disease control[122]. - The company is facing operational risks in the livestock industry due to increased period expenses and a decline in overall gross profit margin, prompting measures to improve performance by expanding sales of self-produced frozen semen and exploring the imported frozen semen market[116]. Acquisitions and Investments - The company completed the acquisition of 96.21% of Elephant Advertising, increasing its total share capital from 197,352,789 to 312,977,396 shares[69]. - The acquisition of Daxiang Advertising diversified the company's business structure, reducing operational risks and enhancing profitability[68]. - The company has committed CNY 10,400 million to entrusted financial management, with an outstanding balance of CNY 3,300 million[107]. - The company has invested RMB 2,561.15 million in the Tianshan Biological Sheep Breeding Project, with 58.32% of the project completed[94]. Future Outlook - The company provided a future outlook projecting a revenue growth of 10% for the second half of 2018, driven by new product launches and market expansion[138]. - The company plans to invest 100 million CNY in R&D for innovative breeding technologies over the next two years[138]. - The company aims to increase its distribution network by 40% by the end of 2019, enhancing product accessibility[138]. - A new marketing strategy focusing on digital channels is expected to increase customer engagement by 50%[139].
天山生物(300313) - 2018 Q1 - 季度财报
2018-04-24 16:00
Financial Performance - Total revenue for Q1 2018 was ¥27,023,861.24, a decrease of 11.04% compared to ¥30,379,094.28 in the same period last year[7] - Net profit attributable to shareholders was -¥5,304,879.54, representing an 8.68% decline from -¥4,881,374.41 year-on-year[7] - Basic and diluted earnings per share were both -¥0.0269, down 8.91% from -¥0.0247 in the same period last year[7] - The company's operating revenue for Q1 2018 was CNY 27,023,861.24, a decrease of 11.04% compared to CNY 30,379,094.28 in the same period last year, primarily due to a decline in sales of frozen semen and meat products[20] - The company reported a significant increase in financing cash inflow, totaling CNY 63,000,000.00, up 38.35% from CNY 45,535,467.48, due to increased inter-company loans[21] - The company reported a total comprehensive loss of CNY 4,985,706.16 for the period, compared to a loss of CNY 1,566,173.56 in the previous period[79] Cash Flow - Net cash flow from operating activities was -¥8,713,418.28, a significant drop of 157.35% compared to ¥15,193,103.78 in the previous year[7] - Cash inflow from operating activities totaled CNY 28,070,949.27, down 64.06% from CNY 78,100,910.82, reflecting reduced revenue from frozen semen and meat sales[21] - Cash outflow from operating activities was CNY 36,784,367.55, a decrease of 41.53% compared to CNY 62,907,807.04, due to lower procurement and payment amounts[21] - The cash flow from financing activities included 45,000,000.00 CNY from borrowings, suggesting reliance on debt financing[86] - The net cash flow from investment activities was -57,081,655.66 CNY, indicating a significant outflow compared to the inflow of 1,068,266.00 CNY[86] - The company is in a position of negative cash flow from both investment and financing activities, which may impact future operational capabilities[86] Assets and Liabilities - Total assets at the end of the reporting period were ¥674,081,482.26, a decrease of 2.44% from ¥690,949,583.86 at the end of the previous year[7] - The company's total assets at the end of Q1 2018 were CNY 749,993,653.97, slightly down from CNY 751,992,328.38 at the beginning of the year[72] - Total liabilities decreased to CNY 257,097,395.69 from CNY 254,110,363.94 at the beginning of the year[72] - The company's equity attributable to shareholders was CNY 354,279,953.23, down from CNY 363,562,015.92 year-on-year[69] Operational Risks and Strategies - The company faces significant risks from animal diseases, which could severely impact production and profitability[10] - The company plans to improve performance by expanding self-produced frozen semen sales and enhancing the quality of beef and lamb products[10] - The company faces operational risks due to market competition in the frozen semen business and the need to improve the competitiveness of its meat products[27] - The company has implemented measures to mitigate disease risks in livestock, including vaccination and biosecurity protocols[29] - The company is adjusting its development strategy to address uncertainties in the breeding market and potential risks in project implementation[30] Investments and Acquisitions - The company has completed the acquisition of the Mingahai Ranch assets in Victoria, Australia, positioning it as a breeding base, with full management rights over the assets[31] - The company is in the process of acquiring 96.21% of Daxiang Advertising Co., Ltd., with a transaction price of 237,261.45 million yuan based on an asset evaluation[43] - The company has shifted from live cattle import business to proxy grazing business, which is currently in its early stages and has low profitability[52] - The company plans to use its own funds to resume the bull semen project when market conditions improve[53] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 11,359[12] - The largest shareholder, Tianshan Animal Husbandry Development Co., Ltd., holds 29.10% of the shares, amounting to 57,426,801 shares[13] - Tianshan Agriculture holds 11,784,511 shares, accounting for 5.97% of the total share capital, with all shares pledged[38] Compliance and Commitments - The company has committed to ensuring that all information provided regarding the transaction is true, accurate, and complete, taking legal responsibility for any misrepresentation[47] - The company will ensure that any necessary related party transactions are conducted at market prices and in compliance with relevant laws and regulations[47] - The company has no instances of non-compliance regarding external guarantees during the reporting period[61]
天山生物(300313) - 2017 Q4 - 年度财报
2018-03-12 16:00
Business Strategy and Operations - The company plans to consolidate and expand its self-produced frozen semen sales while actively exploring the imported frozen semen and sheep frozen semen markets[4]. - The company aims to improve the quality of beef and lamb products to reduce costs and enhance profitability[4]. - The company has transitioned its Australian ranch business to include new proxy farming services in 2017[32]. - The main business includes breeding and selling of cattle and sheep, production and sale of frozen semen and embryos, and consulting services in livestock technology[31]. - The company has developed a comprehensive technical service system for breeding, management, and disease prevention, enhancing economic benefits for farmers[33]. - The company has integrated its breeding business with government poverty alleviation projects, receiving positive feedback from local governments and farmers[56]. - The company aims to optimize its business structure by adding outdoor advertising operations to its existing livestock business[60]. - The company plans to enhance its core competitiveness in the cattle breeding sector by introducing and absorbing high-quality genetic resources and technologies from both domestic and international sources[123]. - The company aims to establish a socialized system integrating breeding, promotion, technical services, and supply chain management for high-quality beef cattle starting in 2018[125]. Financial Performance - The company's operating revenue for 2017 was ¥195,305,726.71, a decrease of 47.95% compared to ¥375,207,065.81 in 2016[21]. - The net profit attributable to shareholders in 2017 was ¥7,444,331.38, a significant turnaround from a loss of ¥139,629,761.39 in 2016, representing a 105.33% increase[21]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥607,774.13, showing a 99.56% improvement from -¥139,703,690.47 in the previous year[21]. - The net cash flow from operating activities for 2017 was ¥78,721,566.09, down 35.29% from ¥121,655,162.23 in 2016[21]. - The basic earnings per share for 2017 was ¥0.04, compared to -¥0.72 in 2016, marking a 105.56% increase[21]. - The total assets at the end of 2017 were ¥690,949,583.86, a decrease of 19.22% from ¥855,368,762.66 at the end of 2016[21]. - The net assets attributable to shareholders at the end of 2017 were ¥363,562,015.92, a slight decrease of 1.11% from ¥367,653,299.24 in 2016[21]. - The weighted average return on net assets for 2017 was 2.05%, a significant improvement from -35.15% in 2016, reflecting a 37.20% increase[21]. - The company reported a gross margin of 44.44% for the livestock sector, despite a 45.57% decline in revenue year-over-year[69]. Risk Management - The company faces significant risks from animal diseases, which can severely impact production and profitability[6]. - The company has implemented measures such as isolation, disinfection, and vaccination to prevent disease outbreaks[6]. - The company is committed to enhancing production management and controlling costs to mitigate performance risks[4]. - The company acknowledges the competitive landscape for its frozen semen products due to market changes and subsidy adjustments[4]. - The company recognizes potential risks associated with the performance of future acquisition targets[4]. - The company is aware of the seasonal revenue fluctuations due to government procurement processes, which may impact quarterly performance[144]. - The company is enhancing its internal control and management systems to mitigate management and human resource risks associated with business expansion[146]. - The company is actively monitoring exchange rate fluctuations to manage risks related to its overseas projects[147]. Market and Competitive Landscape - The company has a leading advantage in genetic resources, owning the most comprehensive North American Holstein gene bank in China[38]. - The company has a technical advantage with a skilled team in bull semen production and advanced breeding technology[39]. - The company operates in Xinjiang, which is the second-largest livestock area in China, with a cattle stock accounting for 20% of the national total[40]. - The company is facing challenges due to a decrease in domestic dairy cow numbers, attributed to competition and environmental regulations[119]. - The domestic market for frozen semen usage is approximately 40% imported and 60% domestic, influenced by government procurement and existing inventory[118]. - The company plans to collaborate with quality enterprises along the beef industry chain to enhance its market position and brand recognition[124]. Investment and Acquisitions - The company acquired 96.21% equity of Elephant Co. for a total transaction value of 237,261.45 million yuan, with cash payment of 57,696.41 million yuan and share payment of 179,565.04 million yuan[59]. - The company has invested in various facilities, including a feed storage building of 624.96 m² and a land area of 14,045.15 m²[45]. - The company has completed the acquisition of assets from the Clark family farm in Victoria, Australia, using AUD 2.525 million of excess raised funds[106]. - The company plans to focus on the development of a grazing business model, shifting from live cattle importation due to market risks and low profitability[101]. - The company has a continuous commitment to fulfill all promises made during the acquisition process, ensuring compliance with relevant laws and regulations[162]. Regulatory Compliance and Governance - The company will not distribute cash dividends or issue bonus shares, nor will it increase capital using reserves[7]. - The company’s profit distribution policy has been compliant with regulations, ensuring transparency and protection of shareholder rights[155]. - The company has committed to compensating for any losses incurred due to unlicensed assets post-restructuring, ensuring financial responsibility[162]. - The company has outlined a strategy to avoid any legal liabilities arising from unlicensed water extraction activities[162]. - The company has engaged Tianjian Accounting Firm for auditing services, with a fee of 600,000 yuan for domestic services and 101,900 yuan for overseas services[168]. Social Responsibility and Community Engagement - The company donated 50 special sheep to the Queren Township in Xinjiang's Mulei County as part of its social responsibility efforts[195].
天山生物(300313) - 2017 Q3 - 季度财报
2017-10-24 16:00
Financial Performance - Operating revenue fell by 51.82% to CNY 59,438,530.75 for the reporting period, and decreased by 58.30% to CNY 139,147,734.31 year-to-date[8] - Net profit attributable to shareholders increased by 107.42% to CNY 2,070,332.12 for the reporting period, and increased by 106.49% to CNY 3,749,995.37 year-to-date[8] - Basic earnings per share rose by 107.42% to CNY 0.0105 for the reporting period, and increased by 106.49% to CNY 0.0190 year-to-date[8] - Operating profit increased to CNY 5,917,359.08, a 107.57% improvement from a loss of CNY 78,183,925.67 in the previous year[19] - Net profit attributable to the parent company reached CNY 3,749,995.37, marking a 106.49% increase from a loss of CNY 57,818,727.51 year-on-year[19] - The company expects to achieve a net profit attributable to the parent company of between 4 million and 5.5 million yuan for the next reporting period, representing an increase of 103% to 104% compared to the same period last year[33] Assets and Liabilities - Total assets decreased by 11.31% to CNY 758,614,026.49 compared to the end of the previous year[8] - The company’s asset-liability ratio stood at 52.28%[19] - The total liabilities decreased from CNY 454,325,727.56 to CNY 396,579,419.96, a reduction of 12.7%[40] - The total owner's equity decreased from CNY 401,043,035.10 to CNY 362,034,606.53, a drop of 9.7%[41] Cash Flow - Cash flow from operating activities decreased by 63.50% to CNY 32,254,149.66 year-to-date[8] - Cash flow from operating activities decreased by 63.13% to CNY 221,291,983.21 compared to CNY 600,180,442.98 in the previous year[20] - The company's cash and cash equivalents dropped significantly from CNY 149,907,879.31 to CNY 68,520,529.74, a decrease of 54.3%[42] - The ending balance of cash and cash equivalents decreased to 14,934,129.74 CNY from 127,528,074.37 CNY in the previous period, reflecting a substantial decline[65] Shareholder Information - The total number of shareholders at the end of the reporting period was 13,665[12] - The largest shareholder, Tianshan Animal Husbandry Development Co., Ltd., held 29.10% of shares, amounting to 57,426,801 shares[12] - The company did not engage in any repurchase transactions during the reporting period[13] Cost Management - The company reported a 73.33% reduction in operating costs, amounting to CNY 89,397,214.86, down from CNY 335,155,202.16[20] - The company's total operating costs decreased to CNY 136,096,322.33 from CNY 411,819,530.21 year-on-year, reflecting a reduction of approximately 66.9%[53] - The company’s management expenses decreased by 32.82% to CNY 29,366,711.18 from CNY 43,712,603.20[20] - The company reported a significant decrease in management expenses, which fell to CNY 4,173,428.13 from CNY 7,514,725.32 year-on-year, a reduction of approximately 44.5%[50] Investment Activities - The company’s investment income increased by 527.31% to CNY 389,029.72 from a loss of CNY 91,042.36 in the previous year[20] - The company incurred financial expenses of ¥4,593,618.85, down from ¥5,308,585.88 in the previous period[57] - The company’s investment activities resulted in a net cash outflow of ¥93,094,211.64, compared to a smaller outflow of ¥7,077,931.79 in the previous period[61] Future Outlook and Strategies - The company provided a positive outlook for the next quarter, projecting a revenue growth of 20% based on current market trends and user acquisition strategies[30] - New product development is underway, with two innovative products expected to launch in Q4 2017, aimed at enhancing market competitiveness[30] - The company is expanding its market presence, targeting an increase in distribution channels by 25% over the next year[30] - A strategic acquisition is planned, which is anticipated to enhance the company's product offerings and market share by 15%[30] - The company has committed to investing 100 million CNY in research and development for new technologies over the next two years[30] Compliance and Governance - The company has committed to ensuring that there will be no overdue or underpayment of social security and housing fund contributions[32] - There were no violations regarding external guarantees during the reporting period[34] - The company reported no non-operating fund occupation by controlling shareholders or their affiliates during the reporting period[35] User and Market Data - User data indicated a rise in active users, with a total of 500,000 new users added in the last quarter, marking a 10% increase compared to the previous quarter[30]
天山生物(300313) - 2017 Q2 - 季度财报
2017-08-11 16:00
Financial Performance - The company achieved a turnaround in performance for the first half of 2017, reporting a net profit of 1,679,663.25 yuan, marking a significant improvement compared to previous years[4]. - Total revenue for the first half of 2017 was ¥79,709,203.56, a decrease of 62.11% compared to ¥210,347,880.87 in the same period of 2016[22]. - Net profit attributable to shareholders was ¥1,679,663.25, representing a 105.24% increase from a loss of ¥29,927,719.31 in the previous year[22]. - The net cash flow from operating activities decreased by 71.52% to ¥21,435,384.36 from ¥75,269,781.75 in the same period last year[22]. - Basic and diluted earnings per share improved to ¥0.0085 from a loss of ¥0.1516, marking a 105.24% increase[22]. - The company reported a loss of 4.5 million yuan from its overseas subsidiary, which shifted its business model from livestock export to ranching[32]. - The company reported a net loss of CNY 122,320,903.92 in retained earnings, slightly improved from a loss of CNY 124,000,567.17[178]. - The company achieved a net profit of 1,679,663.25 CNY in the first half of 2017, marking a turnaround from previous losses[113]. Operational Strategy - The company plans to enhance its business by expanding the sales of self-produced frozen semen and actively exploring the imported frozen semen and sheep frozen semen markets[7]. - The company is working on establishing a complete beef industry chain, including breeding, fattening, slaughtering, and sales, to improve profitability and operational efficiency[7]. - The company is actively promoting the use of sex-sorted frozen semen to improve cattle breeding efficiency and herd expansion[16]. - The implementation of national livestock quality subsidy projects aims to enhance the quality of cattle breeds and increase production efficiency[16]. - The company aims to establish a complete industry chain from breeding to sales, enhancing its production scale and sustainable profitability[35]. - The company is implementing a full industry chain strategy in beef cattle, which includes breeding, fattening, slaughtering, and sales, to improve profitability and operational efficiency[102]. Risk Management - The company faces the risk of stock suspension due to consecutive losses in 2015 and 2016, with potential implications if the 2017 annual audit also shows a loss[4]. - The company is exposed to significant risks from animal diseases, which could severely impact production and operational capabilities[8]. - The company has implemented various measures to mitigate operational risks, including strengthening production management and controlling costs and expenses[7]. - The company is focused on risk management related to exchange rates, aiming to mitigate adverse impacts on overseas projects[108]. - The company is exposed to disease risks in livestock, which can significantly impact production and quality, but has established preventive measures and management practices to mitigate these risks[103]. Financial Position - Total assets at the end of the reporting period were ¥755,720,113.08, down 11.65% from ¥855,368,762.66 at the end of the previous year[22]. - Net assets attributable to shareholders decreased by 2.14% to ¥359,800,564.34 from ¥367,653,299.24 at the end of the previous year[22]. - Cash and cash equivalents decreased by 42.84% compared to the beginning of the period, primarily due to the acquisition of subsidiary equity[30]. - The company reported a significant decrease in sales expenses to ¥4,993,272.09 from ¥10,978,906.80, a decline of approximately 54.5% year-over-year[185]. - The ending balance of cash and cash equivalents decreased to 28,193,267.02 CNY from 133,602,828.50 CNY, highlighting liquidity challenges[195]. Investment and Acquisitions - The company has completed the acquisition of minority shareholder rights in its overseas subsidiary to gain full control over Mingjiah Agriculture[49]. - The company approved the acquisition of Australian assets for AUD 25.25 million, funded by excess and remaining raised funds of AUD 10.25 million, equivalent to approximately RMB 52.94 million[81]. - The company has acquired a 37.65% stake in Zhongao Derun Animal Husbandry Co., optimizing its management structure[98]. - The company plans to use AUD 14.6 million of raised funds to acquire a 37.65% stake in Zhongao Derun and to increase capital for its wholly-owned subsidiary Tianshan Holdings[150]. Market and Sales - The sales revenue from breeding livestock decreased by 94.46% due to the adjustment of the Australian company's business model to focus on proxy grazing[49]. - The sales volume of self-produced frozen semen increased by 46.8% year-on-year, with sales prices rising by 34.68%, leading to a revenue increase of 97.71%[56]. - Milk sales volume grew by 43.62% year-on-year, with sales revenue increasing by 45.67% and unit sales costs decreasing by 33.21%[51]. - The company aims to expand its market share in frozen semen and increase livestock sales through promotional activities during key holidays[99]. Compliance and Governance - The semi-annual report for 2017 has not been audited[123]. - The company has not reported any violations of commitments made to minority shareholders[122]. - The company has a commitment to not engage in any activities that harm its interests or those of its shareholders[121]. - The company has not disclosed any significant litigation matters during the reporting period[72]. - The company has no bankruptcy reorganization matters during the reporting period[124]. Assets and Land Use - The company holds land use rights for a total of 16,568 acres of grassland, valid until November 9, 2025[38]. - The company has a total of 425.7 acres of facility agricultural land with a lease valid until November 10, 2041[38]. - The company has a total of 8,495.85 acres of agricultural development land, valid until February 28, 2046[38]. - The company has a total of 150 acres of facility agricultural land with a lease valid until November 10, 2041[38]. - The company has a total of 250 acres of facility agricultural land with a lease valid until November 10, 2041[38].
天山生物(300313) - 2017 Q1 - 季度财报
2017-04-19 16:00
Financial Performance - Total revenue for Q1 2017 was ¥30,379,094.28, a decrease of 77.22% compared to ¥133,346,556.41 in the same period last year[8] - Net profit attributable to shareholders was -¥4,881,374.41, improving by 70.14% from -¥16,346,221.88 year-on-year[8] - Basic and diluted earnings per share were both -¥0.0247, showing an improvement of 72.49% from -¥0.0899 in the same period last year[8] - The company's operating revenue for the reporting period was CNY 30,379,094.28, a decrease of 77.22% compared to CNY 133,346,556.41 in the same period last year[21] - The company reported a significant increase in investment income, which reached CNY 8,734.74, compared to a loss of CNY 660,508.16 in the previous year, marking a 101.32% improvement[21] - The company’s other comprehensive income improved by 128.54%, reaching CNY 838,097.18, attributed to foreign currency translation differences[21] - The company’s tax and additional fees decreased by 39.67% to CNY 103,983.55, mainly due to reduced sales during the reporting period[21] - The company’s management expenses decreased by 32.77% to CNY 9,579,265.40, reflecting cost-cutting measures and organizational adjustments[21] - The company’s employee compensation payable decreased by 43.83% to CNY 3,081,256.89, due to the payment of last year's unpaid salaries[21] - The company reported a potential turnaround in net profit for the first half of 2017, driven by improved marketing channels for beef and mutton products and the launch of the second-generation Angus cattle[57] Operational Risks - The company faced risks related to the adjustment of the good breed subsidy policy, which could impact production and operations if the policy is canceled or altered[10] - The company is exposed to disease risks in livestock, which could significantly affect production and operational performance[12] - The company is facing operational risks due to the potential cancellation or adjustment of the national subsidy policy for livestock breeding, which could impact production and operations[30] - The company is exposed to significant risks from animal diseases, which can severely affect production and reproduction capabilities, as well as the quality and quantity of frozen semen and milk[31] - The company faces risks related to changes in subsidy policies for high-quality breeding stock, which may impact future operations[28] Business Strategy and Expansion - The company is actively expanding its beef cattle breeding and sales operations to establish a complete industry chain, aiming to enhance profitability[11] - The company is expanding its business by promoting the sale of beef cattle breeding stock and aims to establish a complete industry chain from breeding to sales, but faces challenges with rising costs and declining overall gross margins[30] - The company plans to enhance quality assurance capabilities and sales capabilities as part of its meat cattle strategy, focusing on cost control and efficiency improvement[27] - The company has developed a product line with over 200 products, including Angus beef, and plans to adopt advanced processing standards to meet diverse consumer needs[39] - The company’s "Big Beef Cattle Strategy" aims to ensure product quality and traceability through a controlled supply chain from breeding to sales[40] Financial Management - The company has initiated fundraising projects but faces uncertainties that could affect the timely completion and expected returns of these projects[33] - The company has adjusted its idle fundraising cash management limit to 125 million yuan, generating a return of 250,000 yuan during the reporting period[43] - The total amount of principal-protected financial products issued by the company reached 37,400,000, with 32,400,000 currently outstanding[45] - The company reported a return of 1.28% on a principal-protected financial product issued on March 17, 2017[45] - The company has a commitment to provide accurate and complete information regarding its transactions, ensuring no misleading statements or significant omissions[46] Asset Management - Total assets at the end of the reporting period were ¥860,760,033.08, a slight increase of 0.63% from ¥855,368,762.66 at the end of the previous year[8] - The total current assets reached ¥312,554,716.24, slightly up from ¥312,159,350.46 at the start of the period[63] - The company's total assets increased to CNY 860,760,033.08 from CNY 855,368,762.66, reflecting a growth of approximately 0.46%[66] - The production biological assets increased to CNY 15,815,903.55 from CNY 11,568,479.74, representing a growth of about 36.56%[64] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 9,898[13] - As of the report date, the controlling shareholder has pledged a total of 69,211,312 shares, representing 29.10% of the company's total equity[42] Cash Flow and Liquidity - Cash and cash equivalents decreased to CNY 126,580,130.09 from CNY 149,907,879.31, a drop of approximately 15.53%[67] - The company utilized ¥50 million of idle raised funds for cash management as of March 31, 2017, with the remaining funds held in a dedicated account[63] - The company experienced a decrease in cash and cash equivalents due to negative cash flow from investment and financing activities[83] Project Management - The company has temporarily halted the "bull semen production and development project" due to a decline in market demand, with an original investment plan of 78.39 million CNY adjusted to 41.52 million CNY[52] - The company has received a refund of 38.25 million CNY related to a terminated property purchase agreement, which will be redirected to the information center project using self-owned funds[52] - The company has committed to a total of 22,380.67 million CNY in various projects, with 13,414.85 million CNY already invested[52] Compliance and Governance - The company has not engaged in any non-compliant external guarantees during the reporting period[58] - There were no non-operational fund occupations by controlling shareholders or related parties during the reporting period[59] - The company has made commitments to compensate for any losses incurred due to unlicensed assets involved in its restructuring[46]
天山生物(300313) - 2016 Q4 - 年度财报
2017-03-29 16:00
Financial Performance - The company's operating revenue for 2016 was CNY 375,207,065.81, representing a 51.99% increase compared to CNY 246,867,894.03 in 2015[24]. - The net profit attributable to shareholders was a loss of CNY 139,629,761.39, a decline of 291.56% from a loss of CNY 35,659,960.10 in the previous year[24]. - The net cash flow from operating activities improved to CNY 121,655,162.23, a significant increase of 160.81% compared to a negative cash flow of CNY 200,045,848.82 in 2015[24]. - The total assets at the end of 2016 were CNY 855,368,762.66, down 6.20% from CNY 911,912,787.20 at the end of 2015[24]. - The net assets attributable to shareholders increased by 4.65% to CNY 367,653,299.24 from CNY 351,310,167.76 in 2015[24]. - The basic earnings per share for 2016 was -CNY 0.72, a decrease of 260.00% from -CNY 0.20 in 2015[24]. - The weighted average return on net assets was -35.15%, a decline of 25.61% from -9.54% in the previous year[24]. - The company reported a significant increase in the sales of imported cattle, which rose by 365.88% to 32,733 heads[62]. - The revenue from the livestock export business accounted for 61.19% of total revenue, significantly impacting overall profitability[48]. - The company reported a total asset value of 85,536.88 million yuan, a year-on-year decrease of 6.20%[49]. Operational Challenges - The company faced risks related to the adjustment of the good breed subsidy policy, which may impact production and operations if the policy is canceled or further modified[7]. - The company experienced a decline in comprehensive gross profit margin due to increased operational costs and varied gross profit levels across product categories[8]. - The company reported a loss from the disposal of non-current assets amounting to ¥5,362,666.66, which increased from ¥2,203,864.78 in 2015, primarily due to increased biological asset losses[30]. - The company has been actively promoting the use of frozen semen products to improve cattle breeding efficiency and genetic quality[24]. - The company faces significant risks from animal diseases, which can severely impact production and reproduction capabilities, potentially leading to substantial losses[138]. - The sales of frozen semen products are subject to seasonal fluctuations due to government procurement processes, leading to uneven revenue distribution throughout the year[140]. Strategic Initiatives - The company plans to enhance its performance by expanding self-produced frozen semen sales and actively exploring the imported frozen semen and sheep frozen semen markets[8]. - The company plans to establish three breeding and farming bases in Northwest China, Inner Mongolia, and the Huang-Huai Plain to enhance its ecological and sustainable agricultural model[37]. - The company aims to improve its breeding stock by conducting genomic testing and collaborating with other provinces for data collection to meet new selection criteria[127]. - The company plans to enhance breeding technology R&D and strengthen collaboration with international breeding firms to improve genetic resources and market share in the domestic breeding industry[128]. - The company is implementing a "large beef cattle strategy" to establish a complete industry chain from breeding to sales, aiming to enhance production efficiency and modernize operations[144]. Market Trends - National policies are increasingly supportive of the livestock industry, providing a favorable environment for the company's growth[117]. - China's per capita beef consumption increased from 4.87 kg in 2010 to an estimated 5.49 kg in 2020, reflecting an annual growth rate of 1.13%[119]. - Total beef consumption in China is projected to rise from 721 million tons in 2015 to 796 million tons in 2020, an increase of 75 million tons[120]. - The average domestic beef price rose from 39 RMB/kg in 2009 to 64 RMB/kg in 2014, with a compound annual growth rate of 13.9%[121]. - There is a current supply-demand gap of 500 billion RMB in the beef market, contributing to sustained high beef prices[122]. Investment and Funding - The company has committed to invest RMB 78.39 million in the bull semen production and R&D project, with a cumulative investment of RMB 42.52 million, achieving 54.43% of the planned investment[105]. - The total amount raised from the initial public offering of A-shares was RMB 295.49 million, with a net amount of RMB 260.99 million after deducting various issuance costs, and the excess raised funds amounted to RMB 162.8162 million, of which 6.44% has been used and 95.67% has been cumulatively utilized[107]. - The company has reported a total of 31,460.32 million CNY in raised funds, with 29,835.33 million CNY utilized[106]. - The company has ongoing commitments related to asset restructuring and operational compliance, which may affect future financial performance[159]. Compliance and Governance - The company has confirmed that there were no non-standard audit reports issued for the reporting period[165]. - The company has ensured compliance with social security and housing fund contributions, with no overdue or underpaid contributions reported[162]. - The integrity status of the company and its controlling shareholders is good, with no significant debts overdue or unfulfilled court judgments[171]. - The company has committed to transparency and compliance with regulatory requirements regarding fundraising and project investments[102].
天山生物(300313) - 2016 Q3 - 季度财报
2016-10-24 16:00
Financial Performance - Total operating revenue for the reporting period was CNY 123,378,766.03, an increase of 11.35% year-on-year[8]. - Net profit attributable to shareholders was a loss of CNY 27,891,008.20, a decrease of 582.30% compared to the same period last year[8]. - The company achieved total operating revenue of CNY 333,726,646.90, an increase of 106.95% compared to the same period last year[30]. - The net profit attributable to the parent company was CNY -57,818,727.51, a decrease of 306.62% year-on-year[30]. - The total operating revenue for the third quarter was CNY 123,378,766.03, an increase of 11.4% compared to CNY 110,800,432.47 in the same period last year[66]. - The total operating costs rose to CNY 156,086,207.25, up 34.3% from CNY 116,224,722.89 year-over-year[66]. - The company reported a total loss of CNY 75,406,041.71 for the period, compared to a loss of CNY 19,067,902.91 in the previous year, indicating a worsening financial position[74]. - The total comprehensive income attributable to the parent company was -50,820,175.63 CNY, compared to -23,444,601.07 CNY in the previous period, indicating a significant decline[75]. Assets and Liabilities - Total assets increased by 6.82% to CNY 974,121,837.08 compared to the end of the previous year[8]. - The company's total assets reached CNY 829,387,992.17, compared to CNY 672,026,424.23 at the beginning of the period, reflecting a growth of 23.4%[64]. - Total liabilities amounted to CNY 303,520,826.06, an increase from CNY 273,706,995.23, indicating a rise of 10.0%[64]. - The company's long-term borrowings increased by 388.29% to CNY 70,893,932.87 due to new subsidiary borrowings[30]. - The company's inventory decreased by 38.57% to CNY 126,647,975.03, attributed to sales of previously purchased livestock[30]. Cash Flow - The net cash flow from operating activities for the year-to-date was CNY 88,367,151.31, an increase of 166.95%[8]. - Cash flow from operating activities was CNY 600,180,442.98, representing a year-on-year increase of 185.58%[31]. - The total cash outflow from investing activities was 102,253,479.04 CNY, compared to 140,908,309.93 CNY in the previous period, indicating reduced investment expenditures[81]. - The net cash flow from financing activities was -37,979,778.93 CNY, a decline from a positive inflow of 161,263,589.27 CNY in the previous period, reflecting challenges in financing[82]. Strategic Initiatives - The company plans to expand its entire industry chain from breeding to sales to improve profitability and mitigate performance risks[13]. - The company is actively investing in beef projects to extend its industry chain and enhance market competitiveness[15]. - The company has adjusted its development strategy to implement industrial integration measures, facing potential operational and investment risks due to market demand uncertainties and talent shortages[16]. - The company is focused on establishing a complete industrial chain from breeding to sales, aiming to enhance production scale and modernize operations[19]. - The company is implementing a full industry chain operation for beef production, focusing on breeding, farming, fattening, slaughtering, and sales, ensuring controllable quality from source to end[22]. Risk Management - The company faces risks from government subsidy policies, which could impact production and operations if altered or canceled[12]. - The company has implemented measures to prevent disease outbreaks, which pose significant risks to livestock production[14]. - The company emphasizes the importance of risk management and internal controls to mitigate the impact of price fluctuations in the livestock market[20]. - The company has identified food safety as a critical risk, emphasizing the importance of managing the long supply chain effectively to protect brand reputation[21]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 8,375, with the largest shareholder holding 29.10% of shares[25]. - The largest shareholder, Tianshan Agricultural Development Co., Ltd., holds 57,426,801 shares, which are currently pledged[25]. Investment and Fundraising - Total fundraising amount reached CNY 29,328.47 million, with CNY 847.99 million invested in the current quarter[44]. - The project for bull semen production and research has a total investment of CNY 7,838.65 million, with CNY 4,152.15 million invested to date, achieving 54.43% of the planned progress[44]. - The acquisition of Australian assets project has been fully funded with CNY 5,294.33 million, achieving 100% completion[44]. - The company has committed to ensuring no overdue or underpayment of social security and housing fund contributions[42]. Market Outlook - The company predicts continued growth in beef consumption driven by urbanization and changing consumer preferences for safe and green meat products[20]. - The company plans to increase market share in the fourth quarter in response to the frozen semen bidding policy[36]. - The company aims to leverage the winter sales peak for beef and lamb products to achieve favorable operating results[36].
天山生物(300313) - 2016 Q2 - 季度财报
2016-08-24 16:00
Financial Performance - Total revenue for the reporting period reached ¥210,347,880.87, a significant increase of 316.86% compared to the same period last year[18]. - The net profit attributable to shareholders was -¥29,927,719.31, representing a decline of 195.39% year-on-year[18]. - The net cash flow from operating activities improved to ¥75,269,781.75, a 156.56% increase from -¥133,077,592.74 in the previous year[18]. - Total assets increased by 13.87% to ¥1,038,410,681.52 compared to the end of the previous year[18]. - The equity attributable to shareholders rose by 35.70% to ¥476,726,779.44[18]. - Operating profit was CNY -44,020,388.87, a decrease of 215.33% compared to CNY -13,960,016.24 in the same period last year[30]. - The total profit amounted to CNY -41,879,205.10, representing a decline of 207.73% from CNY -13,608,895.45 year-on-year[30]. - The company reported a net loss of CNY 42,183,639.25, compared to a net loss of CNY 14,028,023.85 in the same period last year, reflecting a 200.71% increase in losses[41]. - The gross margin for the main business fell to 2.10%, down from 38.72% in the previous year, indicating a significant decline in profitability[45]. - The company achieved total operating revenue of CNY 210,347,880.87, a year-on-year increase of 316.86% from CNY 50,459,891.29[30]. Business Strategy and Expansion - The company plans to expand its business by developing a complete beef industry chain, including breeding, fattening, slaughtering, and sales[26]. - The company is extending its business model to cover the entire beef production chain, from breeding to processing and distribution, to improve efficiency and market presence[55]. - The company plans to establish three breeding bases in Xinjiang, Inner Mongolia, and Ningxia, enhancing its market presence and operational capacity[32]. - The company aims to establish a complete industry chain from breeding to beef sales, enhancing economic benefits through resource advantages[63]. - The company is actively promoting the use of sex-sorted frozen semen to control the gender of offspring, enhancing breeding effectiveness[11]. Risks and Challenges - The company faces risks related to government subsidy policies for high-quality dairy cattle, which could impact operations if altered[25]. - The risk of animal diseases remains a significant concern, with measures in place to mitigate this risk through professional veterinary care and biosecurity practices[27]. - The company faces risks from potential changes in good breed subsidy policies, which could impact production and operations[68][69]. - The company is exposed to disease risks that could significantly affect production and operational capabilities[71]. - The company anticipates a potential net loss for the year due to complexities in overseas livestock export and uncertainty regarding the launch of Angus premium meat products[100]. Financial Management and Investments - The company has invested CNY 29,328.47 million in fundraising, with a total of CNY 17,091.25 million already utilized[83]. - The company has a cumulative change in the use of raised funds amounting to CNY 9,818.2 million, representing 33.48% of the total raised funds[83]. - The company has begun implementing fundraising investment projects, but uncertainties remain regarding market conditions that could affect project completion and expected returns[74]. - The company reported a total fundraising amount of RMB 295.49 million, with a net amount of RMB 260.9982 million after deducting issuance costs, and a surplus of RMB 162.8162 million, of which 0.53% has been used in the current period and 89.76% cumulatively[89]. Shareholder and Equity Information - The company reported a total of 1,000 million in principal recovery for the period, with a return of 1.28 million[95]. - The company achieved a return of 1.34 million on a principal of 1,000 million for the financial product in the reporting period[95]. - The company reported a total of 22,939 in financial products, with a yield of 30.69, representing a return of approximately 0.13%[97]. - The total number of shareholders at the end of the reporting period is 9,110[153]. - The company’s total equity at the end of the current period is CNY 527,756,070.13[193]. Compliance and Regulatory Matters - The company has not audited its semi-annual financial report for 2016[135]. - The company received a refund of RMB 38.25 million on April 29, 2016, after terminating a property purchase contract due to ownership defects[89]. - The company will disclose further details regarding the related party transactions in accordance with regulatory requirements[119]. - The company has committed to not transferring or managing its shares during the lock-up period, ensuring compliance with the relevant regulations[134]. Research and Development - Research and development expenses amounted to 1.434 million yuan, representing 0.68% of operating revenue, primarily focused on establishing a breeding value assessment system for bulls[54]. - The company has achieved 54.43% progress in its frozen semen production and research project, with a total investment of CNY 4,152.15 million out of a committed CNY 7,838.65 million[88].
天山生物(300313) - 2016 Q1 - 季度财报
2016-04-19 16:00
Financial Performance - Total revenue for Q1 2016 reached ¥133,346,556.41, a significant increase of 648.15% compared to ¥17,823,490.78 in the same period last year[9] - Net profit attributable to shareholders was -¥16,346,221.88, representing a decline of 101.92% from -¥8,095,342.11 year-on-year[9] - The company reported a net loss with undistributed profits decreasing by 104.59% to CNY -717,027.66, reflecting operational losses during the reporting period[24] - The company's gross profit margin decreased by 28.95 percentage points, with meat product sales prices dropping by 30.4% year-on-year[29] - The net profit for Q1 2016 was a loss of CNY 21,454,585.03, compared to a loss of CNY 9,115,063.07 in the same period last year, indicating a significant increase in losses[77] Cash Flow and Liquidity - Net cash flow from operating activities improved to ¥27,505,651.71, a 129.78% increase from -¥92,360,485.91 in the previous year[9] - The company's cash and cash equivalents increased by 39.62% to CNY 159,323,462.26, primarily due to increased sales receipts and financing borrowings[24] - Cash inflow from operating activities totaled CNY 210.50 million, up 779.48% year-on-year, driven by increased sales of breeding and meat products[28] - Cash outflow from operating activities was CNY 182.99 million, a 57.35% increase year-on-year, primarily due to higher payments for imported breeding stock[28] - The net cash flow from financing activities was 22,096,480.70 CNY, compared to 48,405,255.77 CNY in the previous period, indicating a decrease of approximately 54.4%[87] Assets and Liabilities - Total assets increased by 16.08% to ¥1,058,571,699.19 from ¥911,912,787.20 at the end of the previous year[9] - The company's long-term borrowings rose by 163.01% to CNY 38,186,833.34, attributed to new financing lease borrowings[24] - The total current liability of CNY 344.69 million in short-term loans as of March 31, 2016, compared to CNY 299.61 million at the beginning of the year[68] - Total liabilities rose to CNY 341,961,104.16, compared to CNY 273,706,995.23, marking an increase of around 25%[74] Business Strategy and Expansion - The company plans to expand its business by enhancing its breeding base and establishing a complete beef industry chain, which includes breeding, fattening, slaughtering, and sales[14] - The company is focusing on improving its performance by consolidating and expanding its sales of self-produced frozen semen and actively exploring the imported frozen semen market[14] - The company is pursuing vertical integration strategies, but faces challenges related to market demand uncertainty and potential talent and technology shortages[39] - The acquisition of the Mingahai Ranch in Australia aims to strengthen the company's core business, but changes in policies or market conditions could introduce investment risks[40] Operational Risks and Challenges - The company faces risks related to government subsidy policies for high-quality dairy cattle, which could impact its operations if altered[12] - The company faces significant risks from animal diseases, which can severely impact production and reproduction capabilities, potentially leading to substantial losses[37] - Government procurement processes create seasonal revenue fluctuations, with a significant portion of income dependent on government tenders, leading to quarterly performance volatility[38] - The company is implementing measures to mitigate operational risks, including cost control and enhancing subsidiary management capabilities[14] Shareholder and Compliance Commitments - The company has committed to not allowing major shareholders or actual controllers to participate in the incentive plan, ensuring compliance with the stock option and restricted stock grant rules[44] - The company reported a commitment to extend the lock-up period of shares held by major shareholders for an additional 12 months until April 25, 2016, ensuring stability in shareholding[45] - The company has guaranteed that it has established social security and housing fund accounts for its subsidiaries, with no overdue or underpaid contributions expected[45] - The company has made a commitment to not engage in any activities that would harm the interests of Tianshan Biological and its shareholders[44] Investment and Fund Utilization - The total amount of funds raised in this quarter is RMB 26,099.82 million, with a cumulative usage of 89.22% of the raised funds[49] - The company has invested RMB 2,561.15 million in the breeding project for fine sheep, with a cumulative investment of RMB 1,132.72 million[49] - The project for the production and research of frozen bull semen has a total investment commitment of RMB 7,838.65 million, with a cumulative investment of RMB 4,152.15 million, achieving 54.43% of the planned progress[48] - The company has not achieved the planned investment progress for the frozen bull semen project due to a decline in market demand[48]